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Having confirmed that externally added L-lactate can enter cerebellar granule cells, we investigated whether and how L-lactate is metabolized
by mitochondria from these cells under normal or apoptotic conditions.
(1) L-lactate enters mitochondria, perhaps via an L-lactate/H+ symporter, and is oxidized in amanner stimulated byADP. The existence of an L-lactate
dehydrogenase, located in the inner mitochondrial compartment, was shown by immunological analysis. Neither the protein level nor theKm and
Vmax values changed en route to apoptosis.
(2) In both normal and apoptotic cell homogenates, externally added L-lactate caused reduction of the intramitochondrial pyridine cofactors, inhibited
by phenylsuccinate. This process mirrored L-lactate uptake by mitochondria and occurred with a hyperbolic dependence on L-lactate
concentrations. Pyruvate appeared outside mitochondria as a result of external addition of L-lactate. The rate of the process depended on L-lactate
concentration and showed saturation characteristics. This shows the occurrence of an intracellular L-lactate/pyruvate shuttle, whose activity was
limited by the putative L-lactate/pyruvate antiporter. Both the carriers were different from the monocarboxylate carrier.
(3) L-lactate transport changed en route to apoptosis. Uptake increased in the early phase of apoptosis, but decreased in the late phase with
characteristics of a non-competitive like inhibition. In contrast, the putative L-lactate/pyruvate antiport decreased en route to apoptosis with
characteristics of a competitive like inhibition in early apoptosis, and a mixed non-competitive like inhibition in late apoptosis.
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One of the most outstanding problems in brain bioenergetics
concerns the nature of the cell fuels (see [1]). As far as neurons
are concerned, although evidence that L-lactate (L-LAC) can
constitute an adequate energy substrate for brain tissue was
provided as early as in the 1950s (for refs see [2]), glucose has
long been considered the main substrate for neuronal energy
metabolism, L-LAC being considered a metabolic waste product
and/or a sign of hypoxia in the central nervous system [3]. Over
the years, it was confirmed that L-LAC is efficiently oxidized by
brain cells in vitro. Since L-LAC does not cross the blood–brain
barrier easily, blood-borne L-LAC cannot be a significant source
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astrocytes and released in the extracellular space to form a pool
readily available for neurons in case of high energy demands
[4–9], although this point has been questioned because neurons
express the high-affinity MCT2 that is 60% saturated at the
resting L-LAC level [10]. In this case L-LAC transport across
the plasma membrane was shown (see [11,12]). Similarly,
recent investigation of kinetic parameters and activities of
L-lactate dehydrogenase (LDH) isoenzymes supported the use
of L-LAC by neurons [13].
At present, the role of L-LAC metabolism in neuron activity
remains a matter of debate. In particular, under conditions in
which glucose is required to provide NADPH for fatty acid
synthesis (see [1] and references therein), L-LAC, besides being
incorporated into lipids (see [1] and references therein), could be
the main energy substrate for neurons [14,15]. In particular,
Pellerin et al. [16] proved that the relative contributions of
glucose and L-LAC (5.5 mM each) to neuronal oxidative meta-
bolism amounted to 21% and 79% respectively, thus showing
the major role for L-LAC as an energy source. Consistently, it
was recently proposed that L-LAC is the principal end product of
neuronal aerobic glycolysis [17]. Moreover this could also occur
during neuronal activity thus making L-LAC a suitable indicator
of the coupling between oxygen and glucose consumption [14].
Contrarily, it has been argued that L-LAC does not undergo local
oxidative phosphorylation ruling out that it can be a significant
source of energy for activated neurones [18]. Interestingly, L-
LAC was also found to be a precursor for glutamate and GABA
synthesis [19]. A further role is suggested in cerebellar granule
cells (CGCs) undergoing apoptosis, where L-LAC production is
needed to provide ATP by anaerobic glycolysis, especially when
oxidative phosphorylation is impaired [20].
Until recently the widely accepted view of oxidative L-LAC
metabolism in mammalian tissues has been that it is converted
to PYR in the cytosol, PYR is transferred into mitochondria,
via its own carrier (elsewhere also termed the monocarboxylate
carrier), where it is metabolized via oxidative decarboxylation
and the tricarboxylic acid cycle. In particular, no finding has
been reported of any possible L-LAC metabolism by
mitochondria. Indeed, the existence of lactate dehydrogenase
in mammalian mitochondria (mLDH) was for a long time a
matter of debate. However, following the evidence for L-LAC
oxidation by brain mitochondria [21], in 1971 Baba and
Sharma [22] by using histochemical and electron microscopy
techniques first showed the existence of mLDH localized in the
mitochondria of rat heart and skeletal muscle. Such a proposal
was confirmed later in different laboratories [23–25] even
though it was argued that the mitochondria were contaminated
with cytosolic LDH (cLDH) [26,27]. The existence of mLDH
located in the inner mitochondrial compartments of rat heart
and liver was finally confirmed when it was shown that heart
[28] and liver [29] mitochondria can oxidize L-LAC. An
intracellular L-LAC/PYR shuttle in which various mitochon-
drial carriers, distinct from the monocarboxylate carrier, play
major roles was also shown to exist [28,29]. Interestingly, it
was shown that L-LAC oxidation by rat liver mitochondria can
itself trigger gluconeogenesis in vitro [29].Whether brain mitochondria contain mLDH remains to be
firmly established. Although oxidation of L-LAC by brain
mitochondria was first reported in 1959 [21], one report [23]
has claimed that brain mitochondrial preparations do not
exhibit any mLDH activity in distinction to those from heart,
kidney, liver, and lymphocyte. However, we found that the
amount of ATP produced in S-K5 cells in the presence of
oligomycin, i.e. via substrate level phosphorylation, was higher
than expected based on the amount of L-LAC produced [20],
this suggesting that the L-LAC could be oxidized by
mitochondria. To resolve this issue, having confirmed that
L-LAC can enter CGCs in our experimental conditions, we
have investigated whether mitochondria from control CGCs
and cells undergoing apoptosis can metabolize externally added
L-LAC.
We show first the occurrence of an mLDH located inside
mitochondria isolated from CGCs and suggest that L-LAC
traffic across the mitochondrial membranes takes place me-
diated by two separate novel translocators different from the
monocarboxylate carrier as functionally investigated. In cells en
route to apoptosis neither the activity nor the protein level of
mLDH changes, whereas the transport efficiency of the two
putative L-LAC translocators is modulated differently. We con-
clude that, whatever the detailed mechanism of transport, the in
vitro mitochondrial metabolism of L-LAC in CGCs is regulated
by L-LAC transport into mitochondria.
2. Materials and methods
2.1. Reagents
Tissue culture medium and fetal calf serum were purchased from GIBCO
(Grand Island, NY) and tissue culture dishes were from NUNC (Taastrup,
Denmark). All enzymes and biochemicals were from Sigma Chemicals Co. (St.
Louis, MO, USA). Goat anti-LDH antibody was purchased from Abcam
(Cambridge, MA); mouse monoclonal anti-cytochrome oxidase subunit IV
antibody was purchased from Molecular Probes (Eugene, OR); mouse
monoclonal antibody anti-beta-actin (clone AC40) was purchased from Sigma
(St. Louis, MO); horseradish peroxidase-conjugated anti-mouse or anti-rabbit
antibodies using Enhanced Chemiluminescence Western Blotting reagents were
from Amersham. Protein A/G PLUS-agarose was purchased from Santa Cruz
Biotechnology, Santa Cruz, California USA.
2.2. Cell cultures
Primary cultures of CGCs were obtained from dissociated cerebella of
7-day-old Wistar rats as in Levi et al. [30]. Cells were plated in basal medium
Eagle (BME) supplemented with 10% fetal calf serum, 25 mM KCl, 2 mM
glutamine and 100 μg/ml gentamicin on dishes coated with poly-L-Lysine.
Cells were plated at 2×106 per 35 mm dish, 6×106 per 60 mm dish, or
15×106 per 90 mm dish. Arabinofuranosylcytosine (10 μM) was added to the
culture medium 18–22 h after plating to prevent proliferation of non-neuronal
cells.
2.3. Induction of apoptosis
Apoptosis was induced as in D'Mello et al. [31]. After 6–7 days in vitro
(DIV), cells were washed twice and switched to serum-free BME (S-),
containing 5 mM KCl and supplemented with 2 mM glutamine and 100 μg/ml
gentamicin for the times reported in the figure legends. Control cells were
treated identically but maintained in serum-free BME medium supplemented
with 25 mM KCl for the indicated times; they are referred to as S-K25 cells.
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apoptosis induction will be referred to as xtime-S-K5.
2.4. Cell suspension, homogenate and mitochondria preparations
Before each experiment, the culture medium was removed and the plated
CGCs were washed with phosphate-buffered saline medium (PBS) contain-
ing 138 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 15 mM KH2PO4 pH 7.4,
and then collected by gentle scraping into a volume of medium depending
on the particular experiment.
Cell suspensions showed full viability, even though they lacked the mor-
phological organisation observed in culture dishes such as cell–cell and cell–
substrate contacts, and had no neurites. Cell integrity, which remained essentially
constant for 3–5 h, was quantitatively assessed by confirming the inability of
cells to oxidize externally added succinate, which cannot enter intact cells [32],
by confirming the ability of ouabain to block glucose transport into the cells [33],
and by counting dead cells, identified as large phase-bright cell bodies, as in
Volontè et al. [34]. The final cell suspension routinely contained 85–95% intact
cells and was prepared after 6–7 DIV.
Cell homogenate from a cell suspension was obtained by 10 strokes with a
Dounce Potter homogeniser at room temperature. Rupture of cell membraneswas
checked by confirming the failure of ouabain to inhibit glucose-dependent
oxygen consumption (see above) [33].
Mitochondria were isolated from cell homogenates as in [35]. Briefly, the
cellular homogenate is centrifuged at 1500×g for 10 min. The pellet is resus-
pended and centrifuged at 1500×g for 10 min. The combined supernatants are
centrifuged again at 1500×g for 10 min. The supernatant obtained is centrifuged
at 17,000×g for 11 min. The pellet represents the mitochondrial fraction. All the
operations are made on ice and the centrifugations at 4 °C.
Mitochondria, incubated in PBS, were checked both for their coupling by
measuring the respiratory control index ratio, i.e. (oxygen uptake rate after ADP
addition)/(oxygen uptake rate before ADP addition) which reflects the ability of
mitochondria to produce ATP, and for their intactness by measuring in the post-
mitochondrial supernatant the activities of adenylate kinase (ADK, E.C.2.7.4.3)
and glutamate dehydrogenase (GDH, E.C.1.4.1.3) [36] which are marker
enzymes of the mitochondrial intermembrane space and matrix, respectively.
Protein content was determined according to [37] with bovine serum albumin
used as a standard.
2.5. Immunoblot analysis
Purified mitochondria from either control or apoptotic CGCs were
solubilized in 1% TX-100, 500 mM NaCl, 8 mM MOPS, 0.04 mM EDTA
pH 7.2 for 30 min on ice. Solubilized mitochondrial proteins (4 μg) were
loaded onto a Tricine-SDS polyacrylamide gel [38], separated, and transferred
to a PVDF membrane which was probed with goat anti-LDH antibody.
Monoclonal anti-COX and monoclonal anti-beta-actin antibodies were used as
a loading control for mitochondrial and cytosolic fractions respectively.
Immunoblot analysis was performed with horseradish peroxidase-conjugated
anti-mouse or anti-rabbit antibodies using Enhanced Chemiluminescence
Western Blotting reagents. Relative optical densities and areas of bands were
quantified using a GS-700 Imaging Densitometer implemented with Molecular
Analyst Software (Bio Rad Laboratories).
2.6. mLDH assay
mLDH assay was performed photometrically by means of a Perkin-Elmer
Lambda-5 spectrophotometer at the wavelength 334 nm, at 25 °C, following the
absorbance changes reflecting either NADH oxidation or NAD+ reduction
resulting fromPYRor L-LAC addition, respectively, as a function of time. For the
assays, CGCmitochondria (0.02 mg of mitochondrial protein) were incubated in
phosphate buffer 0.1M pH 7.6 to a final volume of 1ml withNADH (0.2mM), in
the presence of rotenone (0.2 μg/10μl), to avoid NADH oxidation by complex I
when mitochondria are solubilized with TX-100 (0.2%), or NAD+ (1 mM) plus
the detergent TX-100, and the appropriate substrate was then added to start the
reaction. The activity was obtained as the tangent to the initial part of the progress
curves and expressed as NAD+ reduced (NADH oxidized)/min×mg of
mitochondrial protein (ε334 nm=6.22 mM
−1 cm−1).2.7. Polarographic measurements
O2 consumption was measured polarographically using a Gilson 5/6
oxygraph with a Clark electrode, as in [36,39]. Either intact cells or cell
homogenates in PBS (about 1 mg protein) were incubated in a thermostated
(25 °C) water-jacketed glass vessel (final volume 1.5 ml). Since the incubation
chamber required continuous stirring to allow O2 to diffuse freely, the design
included a magnetic stirring system. Oxygen uptake was initiated by adding
L-LAC either to the suspension or to the cell homogenate. The rate of oxygen
uptake was measured from the tangent to the initial part of the progress curve
and expressed as natom O/min×mg protein. The sensitivity of the instrument
was set so as allow rates of O2 uptake as low as 0.5 natom O/min×mg protein to
be measured.
2.8. Fluorescence Emission Spectra of CGCs
Cell suspension (0.5 mg protein) was incubated at 25 °C in 2 ml of PBS and
fluorescence emission spectra (excitation wavelength 334 nm, emission range
400–550 nm) were recorded using an LS50B Luminescence Spectrophotometer
(Perkin-Elmer Applied Biosystems).
2.9. Swelling experiments
Swelling of cell homogenate mitochondria was followed at 25 °C using a
Perkin-Elmer Lambda-5 spectrophotometer at 546 nm. Cell homogenate in PBS
(0.5 mg protein) was rapidly added to isotonic solutions of ammonium salts the
pH of which were adjusted to 7.2, and the decrease in the absorbance was
continuously recorded (see [40]).
2.10. Fluorimetric and photometric assays
Changes in the redox state of mitochondrial pyridine nucleotides were
monitored fluorimetrically, using a Perkin Elmer LS-5 luminometer with exci-
tation and emission wavelengths of 334 nm and 456 nm, respectively. Uptake of
L-LAC was monitored essentially as described (see [41]). Cell homogenate
(1 mg protein) in 2 ml medium consisting of 0.2 M sucrose, 10 mM KCl, 1 mM
MgCl2, 20 mM HEPES–Tris (pH 7.2) was first incubated in the presence of
FCCP (0.12 μM) to oxidize intramitochondrial pyridine nucleotide, and
rotenone (0.2 μg/10 μl) was added 2 min later. The substrate L-LAC was then
added and reduction of intramitochondrial pyridine nucleotides was measured.
PYR appearance outside mitochondria was monitored by using the PYR
detecting system (PDS) (consisting of 0.2 mMNADH plus 1 e.u. LDH) and then
following photometrically NADH oxidation caused by externally added L-LAC,
which per se had no effect on the enzymatic reactions or on the absorbance
measured at 334 nm. In this case the ε334 nm value measured for NADH under
our experimental conditions was found to be 6.5 mM−1 cm−1. In each
experiment, controls were made of the intactness of the mitochondrial inner
membrane by checking the rate of NADH oxidation in the absence of any
substrate. When the rate was higher than 5% of that measured following
metabolite efflux, mitochondria were not used.
It was confirmed that none of the compounds used affected the enzymes in
the metabolite detecting systems. In each experiment NADH was added both in
the sample and in the reference cuvette and the rate of NADH oxidation in the
sample was calculated as the difference between the rates measured in the two
cuvettes. This ensured that the recorded rate of the absorbance change was due
only to reactions outside mitochondria (see [29]).
The rates of both fluorescence and absorbance changes were obtained as
tangents to the initial parts of the progress curve and expressed as nmol NAD
(P)+ reduced (NADH oxidized)/min×mg cell protein, respectively.
2.11. Statistical analysis and computing
All statistical analyses in this study were performed by using SPSS software.
The data were representative of at least three independent neuronal preparations
(with comparable results) each one in independent measurements (in each figure
legend the number of measurements is reported) and are reported as the mean
with the standard deviation (S.D.). Statistical significance of the data was
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hoc Bonferroni test. pb0.05 was considered as significant for all analyses.
Experimental plots were obtained using Grafit (Erithacus software).3. Results
3.1. CGC mitochondria can metabolize externally added L-LAC
In agreement with [12], we have confirmed that externally
added L-LAC can enter CGCs where it is metabolised as an
energetic substrate (Fig. 1). To achieve this we first investigated
whether addition of 3 mM L-LAC, close enough to L-LAC
concentration in the extracellular cerebral fluid (see [11]) to
CGCs could result in oxygen consumption. Oxygen uptake was
found at a rate of 20 natom O/min×mg cell protein (Fig. 1Aa),
and this was completely blocked by oxamate (OXA, 10 mM), aFig. 1. Evidence for L-lactate uptake and metabolism in CGCs. (A) Oxygen uptake by
collected, suspended in 1 ml PBS and incubated in a polarographic vessel at 25 °C and
L-lactate (L-LAC, 3 mM), oxamate (OXA, 10 mM), rotenone (ROT, 0.2 μg/10μl), α-C
natom O/min×mg cell protein. Fluorescence emission spectra of CGCs. Cell suspe
adjusted to 0.25 mg/ml. The spectra of fluorescence emission (λexc=334 nm) were ob
(0.12 μM) (trace a) and then with rotenone (0.2 μg/10μl) for 2 min (trace b), were ad
and spectra were carried out 2 min after each addition. α-CCN−(1 mM) was preincub
times with different cell preparations, giving values with 5–10% variation. Fluoresc
added with glucose. The experiment was carried out as in panel A. At the arr
10 mM), α-CCN−(1 mM), ouabain (OUA, 1 μM), sodium–arsenite (ARS, 2 mM).
min×mg cell protein. Fluorescence emission spectra of CGCs. The experiment w
(trace a) and then with rotenone (0.2 μg/10μl) for 2 min (trace b), were added w
different cell preparations, giving values with 5–10% variation. Fluorescence intespecific inhibitor of L-LDH [42]. In another experiment, the
addition of α-cyanocinnamate (α-CCN−, 1 mM), a powerful
inhibitor of monocarboxylate transport in the cell (see [12]),
resulted in a decrease of oxygen uptake (9 natom O/min×mg
cell protein), whereas this was completely blocked by rotenone
(ROT, 0.2 μg/10μl), an inhibitor of Complex I of the mito-
chondrial respiratory chain (Fig. 1Ab).
In the same experiment, cell emission fluorescence spectra
were carried out, as described in [43], using a wavelength pair
designed to monitor the intracellular NAD(P)/NAD(P)H ox/
redox state (Fig. 1Ac). CGCs were previously incubated with
FCCP (0.12 μM) (trace a) and 2 min later with rotenone (trace
b): these substances caused the oxidation of the intramitochon-
drial NAD(P)H, the level of which was very low, and prevented
the mitochondrial oxidation of the NAD(P)H newly formed by
endogenous substrates, respectively (see Materials and meth-CGCs added with L-lactate. CGCs maintained for 7 DIV (0.9 mg protein) were
oxygen uptake was measured. At the arrows the following additions were made:
CN−(1 mM). Numbers along the curves are rates of oxygen uptake expressed as
nsion CGCs were incubated at 25 °C in 2 ml PBS, with protein concentration
tained as reported in Materials and methods. Cells, previously treated with FCCP
ded with L-LAC (3 mM) in the absence (trace c) or presence of α-CCN−(trace d)
ated with cells 2 min before L-LAC addition. The experiment was repeated four
ence intensity is reported in arbitrary units (a.u.). (B) Oxygen uptake by CGCs
ows the following additions were made: glucose (5 mM), oxamate (OXA,
Numbers along the curves are rates of oxygen uptake expressed as natom O/
as carried out as in panel A. Cells, previously treated with FCCP (0.12 μM)
ith glucose (3 mM) (trace c). The experiment was repeated four times with
nsity is reported in arbitrary units (a.u.).
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due to the intracellular NAD(P)H. Following cell incubation
with 3 mM L-LAC for 1–2 min, an increase of the fluorescence
emission spectra was found (trace c). Such an increase did not
occur when L-LAC was added in the presence of OXA (10 mM)
(not shown), and was partially prevented by α-CCN−(1 mM)
(trace d), which themselves had no effect on the spectra (not
shown). Fig. 1Aa, b, c shows that L-LAC can enter CGCs and
that this occurs in a α-CCN− sensitive manner [12]; once inside
the cell L-LAC causes NAD(P)H formation. This certainly
occurs because L-LAC is oxidized to pyruvate in the cytoplasm
via cLDH, but the possibility also arises that L-LAC is taken up
by mitochondria and oxidized via the mLDH (see below) (see
Scheme 1), both the cytosolic and the putative mitochondrial
L-LAC oxidation being inhibited by OXA.
As a control, the same experiments were carried out by using
glucose (3 mM) as an energy substrate: oxygen uptake was
found at a rate of 16 natom O/min×mg cell protein (Fig. 1Ba).Scheme 1. Transport and metabolism of L-lactate in cerebellar granule cell mitochon
Abbreviations: GLUC, glucose; G6P, glucose 6-phosphate; L-LAC, L-lactate; MIM,
Respiratory Chain. Plasma membrane transporters: GLUT3, neuronal glucose transpo
monocarboxylate transporter; MCT1, MCT4, astrocyte monocarboxylate transpor
L-lactate/pyruvate antiporter; PYR (MCT), pyruvate translocator, i.e. monocarboxy
mitochondrial L-lactate dehydrogenase. In the inset: Changes in the rate of L-lactat
activity (●), L-lactate uptake (Δ) or L-lactate/pyruvate exchange (■) rate, measured af
are reported as a function of the apoptosis time. The rates are expressed as percentaGlucose oxidation was partially prevented by α-CCN−(1 mM)
(4 natom O/min×mg cell protein), which can both enter the
cells [44] and inhibit the mitochondrial PYR carrier [45], but
completely blocked either by ouabain (OUA, 1 μM) (Fig. 1Ba),
which prevents glucose transport in the cell [33], or by arsenite
(ARS, 2 mM), an inhibitor of the pyruvate dehydrogenase
which can enter cells [46], (Fig. 1Bb). Fluorescence spectra of
CGCs incubated with glucose, carried out as described above
for L-LAC (Fig. 1Bc), showed that glucose addition resulted in
an increase of the fluorescence emission of CGCs (trace c)
previously incubated with FCCP (trace a) and with rotenone
(trace b). No change of fluorescence spectra was found in the
presence of OUA (1 mM) (not shown).
Having confirmed that L-LAC can enter CGCs in our
experimental conditions (see also [12]), the next step was to
determine whether externally added L-LAC can enter CGC
mitochondria. This was first done by monitoring mitochondrial
swelling in 100 mM ammonium L-LAC solution, measured as adria and the occurrence of the L-lactate/pyruvate shuttle. For details see the text.
mitochondrial inner membrane; PM, plasma membrane; PYR, pyruvate; R.C.,
rter; GLUT1, astrocyte and endothelial cell glucose transporter; MCT2, neuronal
ters. Mitochondrial translocators: L-LAC, L-lactate/H+ symporter; LAC/PYR,
late translocator. Enzymes: cLDH, cytosolic L-lactate dehydrogenase; mLDH,
e mitochondrial transport and metabolism en route to apoptosis. Either mLDH
ter the addition of 1 mM L-lactate as described for Figs. 3C, 4 and 5, respectively,
ge of the control (equal to 100 at each time).
Fig. 2. Metabolism of externally added L-lactate by CGC mitochondria. (A) Swelling in ammonium L-lactate solution of mitochondria from cells undergoing
apoptosis. In (a) CGC homogenate (0.5 mg protein) from S-K25 cells was added to 0.1 M ammonium phosphate (NH4Pi), 0.1 M ammonium L-lactate (NH4L-LAC),
0.1 M ammonium D-lactate (NH4D-LAC) or 0.25 M sucrose. In (b) CGC homogenate (0.5 mg protein) from either S-K25 or S-K5 cells taken at the indicated times
was rapidly added to 2 ml of 0.1 M ammonium L-lactate (NH4L-LACT). In the table the means±S.D. of the initial swelling rates are reported. Mitochondrial
swelling was monitored as described in Materials and methods. (B) Oxygen uptake by homogenates from CGCs incubated with L-lactate and succinate. Homogenate
(1 mg cell protein) from rat CGCs cultured for 7 DIV was incubated in a polarographic vessel at 25 °C and oxygen uptake was measured as a function of time. At
the arrows the following additions were made: L-lactate (L-LAC, 5 mM), succinate (SUCC, 5 mM), ADP (1 mM), phenylsuccinate (PheSUC, 10 mM), potassium
cyanide (CN−, 1 mM). α-CCN−(1 mM) was added 1 min before L-LAC. Numbers along the curves are rates of oxygen uptake expressed as natom O/min×mg cell
protein. The inset shows a scheme representing mitochondrial L-LAC uptake and oxidation. For details see the text. Main abbreviations: Ac-CoA, acetyl coenzyme A;
ANT, adenine nucleotide translocator; α-CCN−, α-cyanocinnamate, IMS, intermembrane space; L-LAC, l-lactate; mLDH, mitochondrial L-lactate dehydrogenase;
MIM, mitochondrial inner membrane; PheSUC, phenylsuccinate; PYR, pyruvate.
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mitochondria are incubated in an isotonic solution of the
ammonium salt of a penetrant anion (see [40]). Mitochondrial
swelling was monitored in homogenates from either control
cells (S-K25) or from cells undergoing apoptosis at different
times x, expressed in hours (h) or minutes (min), after apoptosis
induction (which will be referred to as xtime-S-K5). In both
cases the assumption is made that the non-mitochondrial
fraction of the homogenate has no effect on the absorbance of
the suspension over the investigated times.
Rapid and extensive swelling of S-K25 homogenate mito-
chondria occurred in 100 mM ammonium L-LAC solution as
shown in Fig. 2Aa. Swelling in 100 mM ammonium D-LAC
occurred at a slower rate and to a lesser extent as in [47]. This
demonstrates that these mitochondria take up L-LAC, likely in a
proton compensated carrier–mediated manner [47]. Both the
rate and the extent of swelling were lower than that which
occurred with 100 mM ammonium phosphate, a highly
penetrant anion (see [41]). No significant swelling was found
in 250 mM sucrose, showing the intactness of the mitochondrial
membranes. Surprisingly enough, swelling of mitochondria
from 1 h-S-K5 cells in ammonium L-LAC occurred with rate and
extent higher (about 280 and 70% respectively) than in the
control (Fig. 2Ab). At longer times of apoptosis both the rate and
extent of swelling decreased to values similar to those of the
control cells, but were lower than those of the control at 8 h.
In a series of experiments, the rates of swelling in ammonium
L-LAC solutions were normalized to that of ammonium phos-
phate in the same experiments. We confirmed statistically thatFig. 3. Western blot of mitochondrial extracts using LDH specific antibody and
LDH assay in mitochondria from cells undergoing apoptosis. (A) Solubilized
mitochondrial proteins (4 μg of total mitochondrial protein loaded in each lane)
from either control (S-K25) or apoptotic (S-K5) cells were obtained at 1 and 5 h
and analyzed by Western blotting analysis using LDH specific antibody, as
described in Materials and methods. Mitochondrial purity was confirmed by
detection of the presence of the mitochondrial marker protein COX and by the
absence of the cytosolic marker protein actin. (B, C) Mitochondrial fractions
(0.02 mg protein), dissolved with TX-100 (0.2%), from S-K25 were incubated
in phosphate buffer 0.1 M pH 7.6 to a final volume of 1 ml and previously added
with rotenone (0.2 μg/10μl) to prevent the NADH oxidation. Both the
dependence of the rate of NADH oxidation on increasing PYR concentrations
(B) and also that of NAD+ reduction on increasing L-LAC concentrations (C)
were measured. When PYR was used as mLDH substrate, mitochondria were
incubated in the presence of TX-100, after which NADH (0.2 mM) followed by
PYR (B) were added to start the reaction. When L-LAC was used as mLDH
substrate, mitochondria were incubated in the presence of TX-100, after which
NAD+ (0.2 mM) followed by L-LAC (C) were added to start the reaction. In the
insets either healthy (a) or solubilized mitochondria (b) (0.02 mg protein) were
used. When PYR was used as mLDH substrate, mitochondria were incubated in
the presence of NADH (0.2 mM) (Ba) or the detergent (Bb) respectively, after
which PYR (0.65 mM) followed by TX-100 (0.2%) (Ba) or NADH (0.2 mM)
followed by PYR (0.65 mM) (Bb) were added to start the reaction. When L-LAC
was used as mLDH substrate, mitochondria were incubated in the presence of
NAD+ (1 mM) (Ca) or TX-100 (0.2%) (Cb) respectively, after which L-LAC
(10 mM) followed by TX-100 (0.2%) (Ca) or NAD+ (0.2 mM) followed by
L-LAC (10 mM) (Cb) were added to start the reaction. Oxamate (OXA, 10 mM)
and phenylsuccinate (PheSUC, 10 mM) were previously incubated with healthy
(in a) or solubilized mitochondria (in b). The rate of absorbance change at
334 nm, measured as the tangent to the initial part of the progress curve, is
expressed as μmol/min×mg mitochondrial protein.the swelling rate up to 1 h after apoptosis induction was signi-
ficantly higher (about 160%) compared with S-K25 cells (see
the table of Fig. 2Awhere the means±S.D. of the initial rates of
swelling are reported).
Having established that L-LAC can enter mitochondria, the
ability of externally added L-LAC to cause uptake of oxygen was
checked using cell homogenates (1 mg cell protein), as in [48]
(Fig. 2B). As a result of the addition of 5 mM L-LAC, either in
the absence or presence of 1 mM α-CCN−, oxygen uptake
occurred at a rate of about 7 natomO/min×mg cell protein (State
4); following addition of 1 mMADP (State 3), an increase in rate
of about 185% was found. The respiratory index, i.e. oxygen
uptake rate after ADP addition/oxygen uptake rate before ADP
addition, with L-LAC was 2.9, showing that mitochondria were
coupled, and more importantly that they can metabolize L-LAC
in an energy competent manner. The intactness of mitochondria
in homogenates was also established by confirming the absence
of activities of adenylate kinase and glutamate dehydrogenase
Table 1













S-K25 15′ 4.9±0.45 0.29±0.005 0.070±0.006 0.57±0.01
S-K5 15′ 4.4±0.49 0.27±0.01 0.065±0.004 0.58±0.01
S-K25 1 h 5.0±0.50 0.30±0.010 0.070±0.005 0.55±0.02
S-K5 1 h 4.7±0.75 0.27±0.02 0.073±0.005 0.52±0.01
S-K25 3 h 4.9±0.35 0.28±0.05 0.070±0.005 0.60±0.03
S-K5 3 h 3.9±0.72 0.28±0.02 0.071±0.002 0.59±0.01
S-K25 8 h 5.2±0.20 0.27±0.02 0.075±0.005 0.57±0.02
S-K5 8 h 3.9±0.45 0.28±0.01 0.076±0.009 0.56±0.02
Mitochondria (0.02 mg protein), from either control (S-K25) or apoptotic (S-K5)
CGCs, were solubilized with TX-100 (0.2%) and then incubated at 25 °C in
phosphate buffer 0.1 M pH 7.6 to a final volume of 1 ml. The assay was performed
as in Fig. 3B and C. The rate of absorbance increase (decrease), measured as the
tangent to the initial part of progress curve, is expressed asμmol of NADP+ reduced
(NADPH oxidized)/min×mg of mitochondrial protein. Results are means with the
standard deviation (±S.D.) of triplicate measurements and representative of at least
5 different experiments carried out with different cell preparations prepared from
different groups of animals. ANOVA and Bonferroni test: no statistically signi-
ficant differences were found for any of the samples at any of the time considered.
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membrane space and matrix respectively, in post-mitochondrial
supernatants (for details see Materials and methods). In the same
experiment, the control respiratory index with succinate used a
respiratory substrate (5 mM) was 3.9. In three separate
experiments oxidation of L-LAC (5 mM) proceeded at rates of
7±4 and 20±5 natom O/min×mg cell protein in states 4 and 3
respectively; in the same experiments, oxygen uptake by cell
homogenates to which succinate (SUCC, 5 mM) had been added
occurred with rates of 24±4 and 95±10 natom O/min×mg cell
protein in states 4 and 3 respectively.
In both cases, phenylsuccinate (PheSUC, 10 mM), a non-
penetrant compound which can inhibit a variety of carriers,
including the L-LAC carriers in heart and liver mitochondria
[28,29], but excluding both the PYR carrier and the ANT (for
refs see [41]), was found to reduce the rate of oxygen con-
sumption due to L-LAC and SUCC (35 and 95%, respectively);
both processes were completely blocked by potassium cyanide
(CN−, 1 mM) which inhibits the cytochrome c oxidase (COX).
The inhibition by PheSUC rules out the possibility that oxygen
uptake was dependent on the oxidation of PYR generated
outside mitochondria, by the action of contaminating cLDH and
NADH, and taken up by mitochondria via its own carrier.Fig. 4. Fluorimetric investigation of the redox state of the intramitochondrial pyridin
protein), in 2 ml medium consisting of 0.2 M sucrose, 10 mMKCl, 1 mMMgCl2, 20 m
times of apoptosis, was incubated at 25 °C and treated with FCCP and then with
fluorimetrically (λexc=334 nm; λem=456 nm) as a function of time. At the arrows L-
(10mM) orα-CCN− (1mM)were previously incubatedwith the homogenate. The rate
curve, is expressed as nmol of intramitochondrial NAD(P)+ reduced/min×mg of cell
homogenate added with 5 mM L-LAC. The inset (b) reports an experiment with added
previously incubated with 1 mM NAD(P)+. The rates of NAD(P)+ reduction are ex
Dependence of the rate of L-lactate uptake as a function of the L-LAC concentration
apoptosis. In the insets are reported the double reciprocal (a) and the Dixon-like (b) plo
In both cases, the rates (V), measured as the tangent to the initial part of the progressSimilar experiments, not reported in detail, were carried out
with homogenates from cells en route to apoptosis. As already
reported in [36] a decrease in the oxygen uptake was found as a
function of time of apoptosis.
A possible explanation of the results in Fig. 2B is the
following: externally added L-LAC enters mitochondria via a
PheSUC-sensitive, but α-CCN− insensitive, carrier. Inside mito-
chondria, L-LAC is oxidized to PYR via a putative mLDH, and
the NADH formed drives formation of the electrochemical
proton gradient used for ATP synthesis and export (see inset to
Fig. 2B).
3.2. The existence of LDH in CGC mitochondria
To confirm that mitochondria from CGCs contain their own
mLDH and to ascertain whether the mLDH protein level
changes en route to apoptosis, an immunological analysis was
carried out by using anti-LDH antibody (Fig. 3A). This showed
the occurrence of the novel mitochondrial LDH at a protein
level essentially similar in mitochondria from either 1 h/5 h-S-
K5 cells or S-K25 at the same time (not shown in detail). Each
mitochondrial sample was also subjected to Western blotting for
beta-actin, as a cytosolic marker, using a monoclonal anti-beta-
actin antibody. No cross reacting material was found even as
monitored for times up to 2 h showing that all mitochondrial
preparations were completely free of cytosolic contamination.
COX was used as a mitochondrial marker. Challenge with a
monoclonal anti-COX subunit IV antibody showed constant
levels of protein at the investigated times.
In parallel, we tried to assay the activity of mLDH in isolated
mitochondria. To do this mitochondria were added to 1-ml
medium containing either NADH (0.2 mM) and PYR (1 mM)
(Fig. 3B) or NAD+(1 mM) and L-LAC (1 mM) (Fig. 3C) to
follow the LDH reaction in the sense of NADH oxidation or
NAD+ reduction respectively, and the absorbance at 334 nm
measured as a function of time (for details see Materials and
methods). No NADH oxidation/NAD+ reduction was found
following the addition of intact mitochondria, previously treated
with rotenone (0.2 μg/10μl) to prevent NADH oxidation, thus
showing the absence of NAD+-linked LDH in the external
mitochondrial compartments. As a result of addition of TX-100
(0.2%) to the mitochondria, LDH activity was found as revealed
by the decrease/increase of absorbance respectively (traces a of
insets to Fig. 3B and C). The same changes were observed when
solubilized mitochondria were used (traces b of insets to Fig. 3B
and C). This shows that mLDH is located in the inner mito-e nucleotides caused by externally added L-lactate. (A) CGC homogenate (1 mg
MHEPES–Tris (pH 7.2), from either S-K25 or S-K5 cells taken at the indicated
rotenone (ROT, 0.2 μg/10μl). Reduction of pyridine nucleotides was followed
lactate (L-LAC, 5 mM) was added to the suspension. Where indicated, PheSUC
of fluorescence increase, measured as the tangent to the initial part of the progress
protein. The inset (a) reports the P/O ratio calculated by adding 0.1 mM ADP to
TX-100: TX-100 addition (0.2%) follows 5 mM L-LAC addition to homogenate
pressed as a percentage of control (100%), i.e. in the absence of TX-100. (B)
was investigated in S-K25 and S-K5 homogenate taken at the indicated times of
ts, obtained by replotting the rate data of panel B as a function of apoptosis times.
curve, are expressed in nmol of NAD(P)+reduced/min×mg cell protein.
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found to completely block the mLDH reaction in whichever
direction it was investigated. In the same experiment, we found
that PheSUC (10 mM) was ineffective in inhibiting the NADH/
NAD+ oxidation/reduction (traces b of insets to Fig. 3B and C).In the light of these results we used the mitochondrial
fractions dissolved with TX-100 both from S-K25 (Fig. 3B and
C, Table 1) and from S-K5 cells at different times after induction
of apoptosis (Table 1) to investigate the kinetic properties of the
enzyme. We measured the dependence of the rate of NADH
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NAD+ reduction on increasing L-LAC concentrations with the
results shown in Fig. 3B and C respectively. Saturation kinetics
were found in both cases. Consistent with the results in Fig. 3A,
no significant differences in Vmax values were found when the
mLDH reaction was monitored with either substrate pair in S-K5
cells undergoing apoptosis compared with S-K25 control cells
(Table 1). Similarly, no changes in the Km values were found.
3.3. L-lactate transport into mitochondria
The stereospecific spontaneous swelling shown in Fig. 2A
may suggest that L-LAC produced in the cytosol can cross the
mitochondrial membrane in a carrier mediated manner which
results in proton compensated L-LAC symport. In order to gain
some insight into this point, we investigated, using a fluorimetric
method, the ability of externally added L-LAC, to reduce the
intramitochondrial pyridine dehydrogenase cofactors (see [41]).
We first checked that in spite of the presence outsidemitochondria
of the cytosolic LDH and of the pyridine nucleotide pool, no
change of fluorescence occurred when L-LAC was added to the
post-mitochondrial supernatant. This allowed us to measure the
reduction of the intramitochondrial NAD(P)+in S-K25 cell
homogenates previously incubated with FCCP and then with
rotenone (see above to Fig. 1). When the fluorescence had
stabilized, addition of L-LAC (5mM) resulted in a fast increase in
fluorescence due to reduction of NAD(P)+(Fig. 4A). The
fluorescence increase was unaffected by α-CCN− (1 mM),
whereas PheSUC (10 mM) largely reduced the rate of L-LAC-
dependent NAD(P)H formation (75% inhibition). In a control
experiment, it was confirmed that PheSUC (10 mM) does not
affect the oxidation of β-hydroxy-butyrate which is known to
enter mitochondria by diffusion [49], thus excluding the
possibility that PheSUC can cause any non-specific effect on
themitochondrialmembrane. To confirm thatmitochondrial LDH
is a pyridine nucleotide-dependent enzyme, in a set of experiment
carried out as in Fig. 2B, the P/O ratio was determined using
0.1 mM ADP and found to be 2.85±0.08 (inset a to Fig. 4A).
To determine whether the rate of oxidation of L-LAC via the
putative LDH was limited by the rate of its uptake, TX-100
(0.2%) was added to the cell homogenate as in [39] (inset b to
Fig. 4A). In this case, 1 mM NADP+ was used as the coenzyme
rather than NAD+, both because of the release of intramitochon-
drial NAD+ which is a result of TX-100 addition and because
the newly synthesized NADPH cannot be oxidized by the
solubilized mitochondria. A large increase (about 200%) in the
rate of pyridine nucleotide reduction was found showing that the
rate of oxidation of L-LAC reflects the rate of L-LAC uptake
across the mitochondrial inner membrane.
To ascertain whether and how L-LAC uptake bymitochondria
could change in apoptosis, the rates of the process were mea-
sured in homogenates from either S-K25 or S-K5 cells taken
at different times after induction of apoptosis. In this case 5 mM
L-LAC was used. Whereas the rate of NAD(P)H formation in
control homogenates remained essentially constant up to 8 h (not
shown), this rate was enhanced in 1 h-S-K5 cells up to about
145% of the control, with a subsequent decrease at longer times:a decrease up to about 65% was found with homogenate from
8 h-S-K5 (Fig. 4A). It should be noted that, because of the
impairment of the ANT known to occur en route to apoptosis
(see [48]), the P/O ratio could not be calculated. Notice that TX-
100 experiment, carried out as reported above, showed that the
rate of fluorescence increase mirrored the rate of L-LAC tran-
sport (see inset b to Fig. 4A).
In the light of the transport paradigm according to which
mitochondria first provide net carbon uptake and then allow
for efflux of newly synthesized compounds (see [41]) and
since the L-LAC/PYR shuttle takes place in heart and liver as
already shown in [28,29], we tried to reconstruct the L-LAC/
PYR shuttle in vitro, as in [28], by checking whether addition
of L-LAC (5 mM) can cause efflux of PYR from the
mitochondria (Fig. 5A); the concentration of PYR outside
mitochondria was negligible as shown by the fact that no
decrease in the absorbance measured at 334 nm was found
when NADH+LDH, i.e. the PYR detecting system, were
added to mitochondrial suspensions. As a result of addition of
5 mM L-LAC, a decrease in absorbance of NADH occurred
with a rate equal to 19 nmol NADH oxidized/min×mg cell
protein, which indicates the appearance of PYR in the extra-
mitochondrial phase. α-CCN−(1 mM) did not affect this rate,
thus showing that the putative L-LAC/PYR antiporter is
distinct from the PYR carrier. PheSUC (10 mM) caused about
60% inhibition of the rate of NADH absorbance decrease.
In a parallel experiment, homogenates were incubated with
LDH plus NADPH (0.2 mM), which cannot be oxidized by
complex I ofmitochondrial respiratory chain, then (5mM) L-LAC
was added; as a result of the addition of the detergent TX-100
(0.2%) (inset to Fig. 5A), an increase (about 300%) in the rate of
NADPH oxidation was found in homogenates from both S-K25
and in S-K5 CGCs (not shown), thus further showing that PYR
efflux across the mitochondrial membrane is the rate limiting step
of the measured rate of absorbance change.
The rates of NADH oxidation caused by addition of 5 mM
L-LAC to S-K5 cell homogenates decreased from 15 to 12 and
finally to 5 nmol NADH oxidized/min/mg cell protein with 1 h,
3 h and 8 h-S-K5 cells respectively.
A possible explanation of these findings is that L-LAC enters
mitochondria via a L-LAC transporter as well as in exchange for
endogenous PYR which originates in the matrix from the action
of the mLDH. The newly synthesized PYR can, in turn, move to
the extramitochondrial phase in exchange for further L-LAC in a
carrier-mediated manner (see Scheme 1).
To gain some insight into the mechanism by which both
control and apoptotic CGCs take up external L-LAC, the de-
pendence of the rate of NAD(P)H formation inside mitochondria
and of the appearance of PYR in the extramitochondrial phase on
increasing L-LAC concentration was investigated with homo-
genates from S-K25 and S-K5 CGCs at different times after
induction of apoptosis (Figs. 4B and 5B). As expected in the
case of a carrier mediated transport, a hyperbolic dependence on
L-LAC concentration was found. Interestingly, for CGCs up to
30 min after induction of apoptosis, a significant increase in
the Vmax values of L-LAC uptake (Fig. 4B and inset a) (see also
Fig. 2) was found with respect to the control (41±4 and 28±
Fig. 5. Photometric investigation of the redox state of the extramitochondrial pyridine nucleotides caused by externally added L-lactate. (A) Appearance of PYR due to
addition of L-LAC (5 mM) to CGC homogenate (1 mg protein) from S-K25 or S-K5 cells at the indicated times after apoptosis induction, incubated in the presence of
the pyruvate detecting system (PDS), was monitored as described in Materials and methods. Where indicated, PheSUC (10 mM) and α-CCN−(1 mM) were previously
incubated with the PDS. The inset reports an experiment with added TX-100: TX-100 (0.2%) addition follows 5 mM L-LAC addition. Experimental conditions are the
same, except that mitochondria were incubated with 0.2 mM NADPH (see Materials and methods). Numbers along the curves are rates of pyridine nucleotide
reduction expressed as a percentage of control (considered as the 100%), i.e. in the absence of TX-100. (B) Dependence of the rate of L-LAC/PYR exchange as a
function of the L-LAC concentration was investigated in S-K25 and S-K5 homogenates taken at the indicated times of apoptosis. In the insets are reported the double
reciprocal (a) and the Dixon-like (b) plots, obtained by replotting the rate data of panel B as a function of apoptosis times, respectively. In both cases, the rates (V),
measured as the tangent to the initial part of the progress curve, are expressed in nmol of NADH oxidized/min×mg cell protein.
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with no change in the Km values, measured as the L-LAC con-
centration which gave half maximum rate of transport, which
were about 1 mM. In 1 h-S-K5 cells the increased Vmax remained
constant, but Km decreased to 0.5 mM. Later en route to apo-
ptosis a large decrease ofVmax of the putative L-LAC translocator
was found (10±2 nmol NAD(P)+reduced/min×mg cell protein
at 8 h), without any substantial change in the Km value (about
0.5 mM) (see also inset to Scheme 1 where the rate of both the
transport and themLDH reaction are reported as a function of the
apoptosis times, as calculated at 1 mM L-LAC).
Conversely, in the case of L-LAC/PYR exchange, early
inhibition was found (Fig. 5B and inset a): up to 3 h apoptosis,
Vmax remained constant, but there was an early decrease in the
affinity for L-LAC with Km value equal to about 3 mM at 3 h
apoptosis, according to competitive-like inhibition. The type of
inhibition changes later: although in 1 h–8 h apoptosis time Km
remained unchanged, decrease of the Vmax with respect to the
control was found 5 h after induction of apoptosis (12±0.8 and
22±1.2 nmol NADH oxidized/min×mg cell protein respective-
ly) with a further decrease to 8 nmol NADH oxidized/min×mg
cell protein at 8 h after apoptosis induction (Fig. 5B) (see also
inset b to Fig. 5B). This clearly shows that a non-competitive-
like inhibition occurs in cells undergoing late apoptosis,
characterized by amarked decrease in the L-LAC/PYR exchange
capacity which takes place later after the initial change in L-LAC
affinity.
When the data in Fig. 4B were plotted as 1/v vs. the apop-
tosis induction time in a Dixon-like plot (see inset b to Fig. 4B),
as expected, an increase in the rate of L-LAC uptake was found
up to 1 h at all the L-LAC concentrations used. Interestingly,
when the experimental points obtained in 1–8 h apoptosis times
were plotted, a non-competitive like inhibition was found at
1–10 mM L-LAC concentrations, thus suggesting that the
already activated uptake decreased as a result of increasing
impairment of the carrier efficiency.
Straight lines were obtained in the case of the L-LAC/PYR
exchange as investigated at all times apoptosis when the data in
Fig. 5B were plotted as 1/v vs. the apoptosis induction time in a
Dixon-like plot (see inset b to Fig. 5B). A statistical analysis
showed that the intercepts to the ordinate axis (both in the
competitive-like and in the non-competitive like inhibition)
obtained by treating the experimental points by linear regression,
coincided with the corresponding experimental controls. This
clearly shows that the measured inhibition is related to the same
parameter measured in the control (see above), i.e. the rate of
L-LAC/PYR exchange.
4. Discussion
4.1. Mitochondrial metabolism of L-lactate in CGCs
Having confirmed that, as needed for the astrocytes-neuron
shuttle to occur [4–9], CGCs can take up externally added
L-LAC [10,12] and metabolize it inside the cell (Fig. 1 and
Scheme 1), we also show for the first time that mitochondria
from neurons, in particular from cerebellar granule cells, canmetabolize externally added L-LAC. Mitochondria take up
L-LAC via a putative L-LAC/H+ symporter and oxidize it via the
NAD(P)-linked mLDH. Moreover, we show that the newly
synthesized PYR can be exported outsidemitochondria by virtue
of the existence of a putative L-LAC/PYR antiporter which
allows for operation of an L-LAC/PYR shuttle which could play
a major role in the oxidation of cytosolic NADH (see Scheme 1).
The existence of mLDH in CGCs was shown by both
immunological (Fig. 3A) and functional studies (Fig. 3B, C). In
this case bioinformatics were of no help since none of the LDH
subunits revealed by a current gene search is predicted to be
targeted to mitochondria. In the light of Fig. 3 we show
that, differently from [50] where the presence of a mitochondrial
L-LAC oxidation complex on the outer surface of the inner
mitochondrial membrane was proposed, mLDH is located in the
mitochondrial inner compartment.
In distinction to what occurs in potato tuber mitochondria, in
which L-LAC oxidation due to the mLDH does not result in the
generation of the electrochemical proton gradient [51], mito-
chondrial oxidation of L-LAC in CGCs occurs in an energy-
competent manner, as shown by the ADP stimulation of oxygen
consumption rate. This means that intramitochondrial PYR and
NADH metabolism and the PYR efflux can drive the reaction
towards products in spite of the thermodynamic imbalance.
It should be emphasised that we have provided the first
functional evidence for the existence of two putative transloca-
tors which allow for L-LAC traffic across the mitochondrial
membrane: a putative L-LAC/H+ symporter and a putative
L-LAC/PYR antiporter (see Scheme 1). In distinction with what
occurs for L-LAC transport into the cells (see [10–12]), current
database searching yields no information on L-LAC transport
across the mitochondrial inner membrane because even though
many genes are reported to be mitochondrial carriers, most of
them have no function assigned to them. The clear lesson from
this is that functional studies remain essential to improve know-
ledge of mitochondrial transport and metabolism. That being
said, not all experimental techniques frequently used to study
transport processes were available to us. In particular, for
technical reasons including the low amount of cell homogenate
and the inadequacy of isotopic techniques for the study of
transport processes in which metabolites newly synthesized in
the mitochondrial matrix are exported outside mitochondria still
labelled (see [41]), a detailed investigation of L-LAC transport
by using labelled compounds was impossible. In the present
work we resorted to the use of spectroscopic techniques using
mitochondria in which metabolic processes were essentially
unaffected. The saturation kinetics (with Vmax values different
for the investigated transports) and the inhibition by non-
penetrant compounds strongly suggest the occurrence of
transport processes mediated by two separate translocators
which are also different from the PYR (monocarboxylate) carrier
(see Figs. 4 and 5).
In any cases the rate of transport across the mitochondrial
membranes regulates the L-LAC metabolism as shown by the
TX-100 experiments.
This paper provides a novel mechanism for L-LAC meta-
bolism in the brain in which mitochondria play a major role (see
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glucose (see [1,10–12]), is transported to the extracellular space
and to the neurons via MCT1 and MCT4, and MCT2 respec-
tively, in the intercellular L-lactate shuttle [4–6,10,11,25]. Inside
neurons, in addition to cytosolic oxidation of L-LAC via the
cLDH, mitochondria themselves can contribute to the removal
of cytosolic L-LAC by importing it via the putative L-LAC
translocators and by oxidizing it to PYR via mLDH. The newly
synthesized PYR can efflux from mitochondria via the putative
L-LAC/PYR antiporter, thus constituting an intracellular L-LAC/
PYR shuttle (see below). It was argued that since the NAD+/
NADH ratio is about 1000 in liver cytosol and less than 10 in the
matrix (see [18]), this should prevent any mitochondrial L-LAC
metabolism since the lactate/pyruvate ratio is about 100 times
higher in the mitochondria than in the cytoplasm; accordingly,
L-LAC oxidation is basically much more likely in the cytoplasm
than in the mitochondria. However given that in brain
mitochondria the NAD+ concentration is 8–20 fold higher
than that of NADH [52] and that PYR is actively oxidized via
PYR dehydrogenase [53], we suggest that mLDH in vivo
catalyses essentially L-LAC oxidation. Ultimately, the removal
of the oxidation product by carrier mediated transport and mito-
chondrial metabolism overcomes any thermodynamic difficulty.
Although a significant portion was incorporated into lipids,
mostly sterols, in early neonatal rat brain L-LAC was mainly
oxidized to CO2 (see [1,21] and references therein). Our finding,
obtained with cells in growth, is consistent with this (see [1] and
references therein) and we might suggest that in this case L-LAC
is taken up by its own carrier; because of mLDH activity, the net
carbon uptake results in PYR formation (see Scheme 1).
Interestingly, the Km for L-LAC of the L-LAC/H
+ symporter is
quite close to the cytosolic L-LAC concentration (0.5 and 1 mM,
respectively), thus suggesting that its activity would be respon-
sive to L-LAC concentration changes which could occur within
the cytosol.
On the other hand, our results are consistent with the postulate/
proposal of Schurr (see [2,17]) that L-LAC is the only major
product of cerebral glycolysis and that it can bemetabolised inside
mitochondria. The mLDH whose existence we have shown may
be the hypothesized LDH1 suggested to be the mitochondrial
isoform which converts L-LAC to PYR, as the first enzyme of the
mitochondrial oxidative pathway, supplying PYR to the tricar-
boxylic acid cycle. However, in distinction to Schurr [2], we show
that L-LAC traffic across themitochondrial membranes occurs via
two separate carriers distinct from that which transports PYR
(MCTin Schurr's terms) and that themLDH is located in the inner
mitochondrial compartment.
The role of the L-LAC carriers in neuronal metabolism
requires comment. In agreement with the metabolite transport
paradigm (see [41]), the putative L-LAC/H+ symporter allows
for net uptake of L-LAC, while the putative L-LAC/PYR anti-
porter participates in the L-LAC/PYR shuttle, reconstructed
here, which can contribute to the oxidation of cytosolic NADH.
Indeed, such a transfer of reducing equivalents is essential for
maintaining the favourable NAD+/NADH ratio required for the
oxidative metabolism of glucose and synthesis of neurotrans-
mitters in brain. Notice that in addition to the malate–aspartateshuttle and the glycerol–phosphate shuttle (see [5,43]), we have
already shown the occurrence of the malate/oxaloacetate shuttle
in brain [54] and in particular in CGCs [43]. The results that
we report here add the L-LAC/PYR shuttle as a contributor to
oxidation of external NADH. Comparison made between this
shuttle and the glycerol–phosphate and the malate/oxaloacetate
shuttles suggests that the L-LAC/PYR shuttle plays a major role:
we calculate that at physiological cytosolic substrate concentra-
tion (about 1 mM) [55,56] the rates of NADH oxidation would
be about 5, 8 and 13 nmol/min×mg cell homogenate for the
glycerol-3-phosphate, malate/oxaloacetate and L-LAC/PYR
systems respectively. At present we have no conclusive data
on the contribution of the malate/aspartate shuttle, however ini-
tial experiments dealing with the reconstruction of the malate/
aspartate shuttle, as in [43], suggests a minor role for this shuttle.
4.2. L-Lactate mitochondrial metabolism in CGCs undergoing
apoptosis
We have previously shown that L-LAC production increases
in CGCs en route to apoptosis [20], and hence a mechanism is
required to remove extra cytosolic L-LAC. Thus we propose
that mitochondria, at least in the early phase of apoptosis as well
as at high L-LAC cytosolic concentration, work as a safety valve
to remove excess L-LAC. One could argue that cytosolic L-LAC
can be exported by neurons via the plasma membrane MCT2
(see [12,57]), but this seems to be improbable on the basis of
both the L-LAC concentration gradient between the extracellu-
lar and intracellular phases within the brain and the kinetic
properties of the specific neuronal monocarboxylate transporter
which has high affinity for extracellular L-LAC [11,55,58].
Thus, although the basic mitochondrial L-LAC metabolism
in S-K5 cells is similar to that of the S-K25 cells, we show that
L-LAC metabolism changes in CGCs en route to apoptosis as a
response to the apoptosis dependent cell modifications (see the
inset to Scheme 1). In the light of (Fig. 3, Table 1), we conclude
that any change in L-LAC metabolism in CGCs en route to
apoptosis does not depend on mLDH activity, but on the carrier
mediated transport which regulates, at least in vitro, L-LAC
mitochondrial metabolism in both normal and apoptotic CGCs.
In early apoptosis, in spite of initial impairment of the oxi-
dative phosphorylation, ATP is needed to activate the caspase
cascade together with the released cytochrome c [59]. Thus,
since in early apoptosis, increase in the Vmax without substantial
changes in Km is found, we propose that L-LAC mitochondrial
metabolism plays a double role: it removes L-LAC from the
cytosol, thus preventing cell acidification (see [60]), and
favours ATP production by supplying carbon skeleton to
mitochondria, these processes decreasing with the apoptosis
progression. At longer times of apoptosis a mixed non-
competitive-like inhibition of the L-LAC uptake was found,
perhaps as a consequence of the mitochondrial damage. How
early activation and late impairment of the carrier occur remains
a matter of investigation, however since increase of ROS
production occurs in the early phase of apoptosis with caspase
activation occurring essentially later [61], we might speculate
that the increase of the L-LAC symporter activity over the first
1298 A. Atlante et al. / Biochimica et Biophysica Acta 1767 (2007) 1285–1299hour of apoptosis is a ROS-dependent activation, whereas the
caspase-dependent inhibition might occur later, following
caspase activation. Notice that since in early apoptosis a
gradual impairment of the generation of the electrochemical
proton gradient takes place, an energy dependent increase of the
L-LAC transport can be ruled out.
In contrast, the putative L-LAC/PYR antiporter, as investi-
gated in S-K5 cells during apoptosis, is inhibited already in the
early apoptosis, perhaps due to increasing impairment of the
mitochondrial metabolism in which no shuttle is required. The
impairment of the putative L-LAC/PYR antiporter occurs in a
double manner as already shown for the adenine nucleotide
translocator [48]. In early apoptosis, the inhibition takes place in
a competitive-like manner (no change in the Vmax and increase in
Km), whereas at longer time there is a decrease in the transport
efficiency (Vmax), without further Km change as in a non-
competitive like inhibition. As stressed above, we maintain the
hypothesis that the initial inhibition is ROS-dependent, whereas
the late inhibition might be caspase-dependent. Whether and
how ROS production and caspase activation can affect L-LAC
transport via the two carriers is at present under investigation
using CGCs undergoing apoptosis under conditions in which
antioxidant and/or proteolytic systems are selectively blocked,
as in [61].
Thus we conclude that the fate of L-LAC produced in the
neurons during apoptosis is also linked to the novel mitochon-
drial metabolism described in this paper.
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